U.S. Department of Health and Human Services
Aaron Pawlyk
 

 Contact Info

 
Tel: 301-451-7299
Email: pawlykac@mail.nih.gov
 

 Select Experience

 
  • Adjunct Assistant ProfessorDepartment of Pharmacology and Physiology, Drexel University College of Medicine2010-2013
  • Adjunct Professor of PharmacologyPennsylvania Drug Discovery Institute2010-2011
  • Director of PharmacologyALS Biopharma2009-2011
  • Ph.D.Texas A&M University2001

Aaron Pawlyk, Ph.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities & Activities

I am director of the Diabetes and Endocrine Disease Translational Research program.  This portfolio supports a variety of research relevant to the development of therapies for diabetes, endocrine, and metabolic disorders.  This includes research on physiological and pathophysiological processes, molecular structures or biological pathways, and the bioavailability of compounds.  Studies in this portfolio examine the ability to selectively modulate the function of drug discovery targets and the ability to translate biological endpoints of preclinical research to the clinic.

The Diabetes Genetics and Genomics program supports research on the genetic and epigenetic variations that influence the effectiveness and safety of pharmacotherapy for diabetes and other disorders of interest.  The portfolio promotes efforts to build a strong evidence base for personalized medicine and to translate these and other findings into clinical practice.

My other professional activities include participating in several NIDDK working groups—including ones that focus on type 2 diabetes, obesity, and clinical studies, as well as leading the trans-NIDDK Translational Sciences Working Group.

​Research Programs

Diabetes Genetics and Genomics
This program advances research to identify the genetic mechanisms underlying type 1 and type 2 diabetes—and how genetic and epigenetic variation influences the metabolism of therapeutics—with an aim towards developing better treatments

Diabetes, Endocrine, and Metabolic Disease Translational Research
The Diabetes and Endocrine Disease Translational Research program promotes research that translates scientific findings into practice to enhance human health of those with, or at risk for, metabolic disease, including diabetes and endocrine diseases

Current Committee Memberships

  • NIH Common Fund Illuminating the Druggable Genome Working GroupCoordinator
  • NIDDK Type 2 Diabetes Working GroupMember
  • NIH Gerosciences Interest GroupMember
  • NIDDK Obesity Working GroupMember
  • NIDDK Translational Sciences Working GroupChair